Pfizer Inc (PFE)
25.40
-0.28
(-1.11%)
USD |
NYSE |
Apr 17, 16:00
25.43
+0.02
(+0.10%)
After-Hours: 16:57
Pfizer Net Income (TTM): 2.119B for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 2.119B |
September 30, 2023 | 10.48B |
June 30, 2023 | 21.47B |
March 31, 2023 | 29.05B |
December 31, 2022 | 31.37B |
September 30, 2022 | 29.77B |
June 30, 2022 | 29.31B |
March 31, 2022 | 24.97B |
December 31, 2021 | 21.98B |
September 30, 2021 | 19.43B |
June 30, 2021 | 12.76B |
March 31, 2021 | 10.68B |
December 31, 2020 | 9.159B |
September 30, 2020 | 7.73B |
June 30, 2020 | 13.94B |
March 31, 2020 | 15.50B |
December 31, 2019 | 16.03B |
September 30, 2019 | 16.22B |
June 30, 2019 | 12.65B |
March 31, 2019 | 11.48B |
December 31, 2018 | 11.15B |
September 30, 2018 | 23.82B |
June 30, 2018 | 22.55B |
March 31, 2018 | 21.75B |
December 31, 2017 | 21.31B |
Date | Value |
---|---|
September 30, 2017 | 9.809B |
June 30, 2017 | 8.324B |
March 31, 2017 | 7.298B |
December 31, 2016 | 7.215B |
September 30, 2016 | 6.268B |
June 30, 2016 | 7.043B |
March 31, 2016 | 7.622B |
December 31, 2015 | 6.96B |
September 30, 2015 | 8.36B |
June 30, 2015 | 8.896B |
March 31, 2015 | 9.182B |
December 31, 2014 | 9.135B |
September 30, 2014 | 10.48B |
June 30, 2014 | 10.40B |
March 31, 2014 | 21.58B |
December 31, 2013 | 22.00B |
September 30, 2013 | 25.75B |
June 30, 2013 | 26.37B |
March 31, 2013 | 15.53B |
December 31, 2012 | 14.57B |
September 30, 2012 | 9.694B |
June 30, 2012 | 10.22B |
March 31, 2012 | 9.581B |
December 31, 2011 | 10.01B |
September 30, 2011 | 11.46B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
2.119B
Minimum
Dec 2023
31.37B
Maximum
Dec 2022
17.61B
Average
16.03B
Median
Dec 2019
Net Income (TTM) Benchmarks
Amgen Inc | 6.717B |
Gilead Sciences Inc | 5.664B |
Johnson & Johnson | 35.15B |
Viking Therapeutics Inc | -85.90M |
Moderna Inc | -4.714B |